This action might not be possible to undo. Are you sure you want to continue?
By: mohamed badrawy
Classify Companies By Country
Country 1-AUSTRALIA 2-AUSTRIA 3-BELGIUM 4BELGIUM/NETHE RLAND 5-BRAZIL 6-BRITIAN 7BRITIAN/NETHE RLAND 8-CANADA 9-CHINA 10-DENMARK 11-FINLAND 12-FRANCE 13-GERMANY # 8 3 5 1 Country 14-INDIA 15-IRELAND 16-ITALY 17-JAPAN # 8 2 11 71 Country 27-SOUTH KOREA 28-SPAIN 29-SWEDEN 30-SWITZERLAND # 10 10 5 15
7 29 1
18-LUXEMBOURG 19-MAYLASIA 20-MEXICO
1 1 2
31-TAIWAN 32-THAILAND 33-TURKEY
8 1 1
11 46 2 1 39 37
21-NETHERLANDS 22-NORWAY 23-POLAND 24-RUSSIA 25-SAUDI ARABIA 26-SINGAPORE
13 1 1 6 1 2
of Companies 160 157 183 .Classify By Regions REGION AMERICAS ASIA PACIFIC & AUSTRALIA EUROPE No.
OF COMPANIES 7 11 2 139 1 .S VENEZUELA NO.AMERICA¶S COUNTRY BRAZIL CANADA MEXICO U.
OF COMPANIES 8 46 8 71 1 1 2 10 8 1 1 .ASIA PACIFIC COUNTRY AUSTRALIA CHINA INDIA JAPAN MALAYSIA SAUDI ARABIA SINGAORE SOUTH KOREA TAIWAN THAILAND TURKEY NO.
OF COMPANIES 3 5 1 29 1 2 1 39 37 2 COUNTRY ITALY LUXEMBOURG NETHERLANDS NORWAY POLAND RUSSIA SPAIN SWEDEN SWITZERLAND NO. OF COMPANIES 11 1 13 1 1 6 10 5 15 .EUROPE COUNTRY AUSTRIA BELGIUM BELGIUM/NETH ERLANDS BRITAN BRITAIN/NETH ERLANDS DENMARK FINLAND FRANCE GERMANY IRELAND NO.
5 4.6 9 7. and Freight Delivery 15. Construction Mining.8 5.4 Aerospace and Defense Network and Other Communications 21.5 Banks: Commercial and Savings 22. Glass 25.8 9.2 5.9 Entertainment 14.7 5.4 .3 Mail.8 6.8 4.6 -2. Crude-Oil Production Utilities Beverages Trading Shipping Chemicals Industrial Machinery Specialty Retailers Food Consumer Products Telecommunications Household and Personal Products Food and Drug Stores Health Care: Insurance and Managed Care 48.1 Building Materials.9 0.4 -3. Office Equipment 12. Health (stock) 9 Motor Vehicles and Parts 8.3 -2.6 Food Production Energy Petroleum Refining Diversified Financials Metals Engineering.8 Insurance: Property and Casualty (Stock) 9. Package.1 1.1 7 6. 9.9 General Merchandisers 13.7 Electronics.2 Equipment 19.3 Computers.8 Food and Drug Stores 27.5 Airlines 10.3 Pharmaceuticals 13.4 Wholesalers: Health Care 19.6 Insurance: Life.9 Household and Personal Products 27.Classify By Industry Industry % change from 2007 Industry % change from 2007 9.9 4.8 Telecommunications 34. Electrical Equip.
Pharmaceuticals y Top 5 companies: 1-Johnson & Johnson 2-Pfizer 3-GalaxoSmithKline 4-Roche Group 5-Sanofi-Aventis .
MISSION (CREDO) : Our Credo We believe our first responsibility is to the doctors. nurses and .
We must be good citizens-support good works and charities and bear our fair share of taxes.We must provide competent management. We are responsible to the communities in which we live and work and to the world community as well. and their actions must be just and ethical. Business must make a sound profit. the stockholders should realize a fair return. new facilities provided and new products launched. Our final responsibility is to our stockholders. When we operate according to these principles. . We must experiment with new ideas. New equipment must be purchased. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use. Research must be carried on. protecting the environment and natural resources. innovative programs developed and mistakes paid for. Reserves must be created to provide for adverse times.
Product Mix: Three segments:Consumer Pharmaceutical Medical Devices and Diagnostics Consumer .
Consumer Products: 1) Baby Care 2) Skin & Hair Care 3) Wound Care & Topical 4) Oral Health Care 5) Women¶s Health 6) Over-the-counter Medicines 7) Nutritionals 8) Vision Care .
Medical Devices & Diagnostics 1) Orthopaedics 2) Implants 3) Joint Replacements 4) Sports Medicine and trauma 5) Heart & Vascular Disease 6) Coronary Artery Disease 7) Peripheral Vascular And Obstructive Disease 8) Neurological Disease 9) Arrhythmias 10) Diabetes 11) Self-Measured Blood Glucose Monitors 12)Insulin Delivery Devices 13) Medical Diagnostics 14) Blood Screening 15) Clinical Lab Equipment 16) Diagnostic Tests & Molecular Diagnostics 17) Vision Care 18) General Surgery 19) Bariatric Surgery Of Obesity 20) Urologic Surgery 21) Hernia Surgery 22) Women¶s Health & Urology 23) Plastic Surgery 24) Surgical Instruments and Infection Prevention .
The Pharmaceutical segment's broad portfolio focuses on unmet medical needs across several therapeutic areas: oncology. contraceptive. oncology. pain management. immunology. neuroscience. hematology. gastrointestinal. immunology. . cardiovascular and metabolism. Below are some of our main products. infectious disease. dermatology. urology and virology fields. cardiovascular. antipsychotic. neurology. It includes products in the anti-infective.
ITS TENETS DEMAND A SPECIAL LEVEL OF RESPONSIBILITY « FIRST TO PATIENTS AND CUSTOMERS. OUR PEOPLE AND OUR CREDO SET US APART.WE ARE NOT PERFECT.OUR ENDURING STRENGTHWITH THE CHALLENGES OF 2010. OUR COMMUNITIES AND OUR SHAREHOLDERS. AND WHEN WE DO. WE ARE REMINDED MORE THAN EVER OF OUR HERITAGE. DESPITE DIVERSE BUSINESSES. AND THE PROFESSIONALS WHO SUPPORT THEIR HEALTH. THE FAMILIES AND CHILDREN WE TOUCH. WE HOLD OURSELVES ACCOUNTABLE TO CORRECT THEM.OUR PRODUCTS. IT IS A QUIET SENSE OF PURPOSE FOCUSED AROUND THE LIVES WE AFFECT. WE ARE UNITED BY AN EXTRAORDINARY BOND²A COMMITMENT TO CARING FOR ONE PERSON AT A TIME AND TOUCHING THE WORLD² ORIGINATING FROM OUR CREDO VALUES.ANOTHER ENDURING STRENGTH IS THE CHARACTER OF THE PEOPLE OF JOHNSON & JOHNSON. UNWAVERING COMMITMENT TO THE PRINCIPLES EMBODIED IN OUR CREDO AND AN APPRECIATION FOR THE ELEMENTS OF OUR OPERATING MODEL ARE AS STRONG TODAY AS AT ANY TIME IN OUR HISTORY. THEN TO OUR EMPLOYEES. OUR CREDO REMAINS OUR NORTH STAR. WE WILL MAKE MISTAKES. . OUR PIPELINE AND OUR GLOBAL PRESENCE MAKE US STRONG AS A COMPANY. AND WITHIN THE CONTEXT OF OUR 125TH ANNIVERSARY IN 2011. THAT ACCOUNTABILITY IS INHERENT IN OUR CREDO.
" .Pfizer Mission Statement: "We will become the world's most valued company to patients. investors. business partners. customers. colleagues. and the communities where we work and live.
Product Mix 1)Human Health a) OTC Products b) Prescription Products 2) Animal Health .
Each of these businesses is led by an executive with clear accountability for results . Specialty Care. including vaccines. Nutrition.from product development following proof of concept to providing access to patients and through to the end of the product's life cycle. Consumer Healthcare. forging partnerships with key customers.Pfizer has also developed an enhanced commercial operating structure. and The BioTherapeutics Research & Development Group focuses on largemolecule research. Pfizer has created two distinct research organizations. Pfizer has nine diverse health care businesses: Primary Care. and bring more innovative medicines to more patients more quickly. investing in new technologies to add value to our core product offerings. and acquiring new products and services from outside the company.With this structure.To maximize new opportunities in biomedical research. Established Products. . Oncology. The businesses are provided with the resources to pursue attractive growth opportunities and to deliver benefits to all who rely on us around the world. The PharmaTherapeutics Research & Development Group focuses on the discovery of small molecules and related modalities. Emerging Markets. Animal Health and Capsugel. entering into copromotion and licensing agreements. we are able to rapidly capitalize on opportunities to advance our business by increasing support for successful new medicines.
MISSION: The pharmaceutical industry is experiencing a time of unprecedented challenge. regulatory issues and increased pressures from healthcare providers have combined to create an environment where our sector is associated with lower growth and higher risk. less risk and an improved financial performance. . We are addressing these challenges through three key strategic priorities that we believe will transform GSK into a company that delivers more growth. Patent expiries.
Product Mix 1-Prescription medicines 2-Consumer Healthcare 3-Vaccines 4-Stieffel .
CEO Andrew Witty said. .Three strategic priorities in 2008. "Our strategy is delivering and I believe that GSK is now moving to a position where we can deliver our goal of long-term sustainable financial performance. we established the following three strategic priorities: Grow a diversified global business Deliver more products of value Simplify the operating model Announcing GSK s 2009 Annual Results. 2009 saw GSK return to sales growth and I am confident of our prospects on 2010".
Our goals are to: Provide timely. prospective investors and the wider investment community. consistent and accurate information to all shareholders and prospective investors to aid them in assessing the value of Roche and to make informed investment decisions Facilitate dialogue between Roche management and the investment community Achieve a fair valuation of Roche by the financial markets . transparently and consistently in accordance with company polices and relevant securities rules and laws. The role of Investor Relations is to manage these relationships efficiently.Roche maintains open and honest relationships with our shareholders. relevant.
Oncology 2-Virology 3-Inflammation 4-Metabolic Disorders 5-Central Nervous System B) Solutions for Diagnostics C) Products for Researchers .A) Pharmaceuticals 1.
diagnostic tests and services offering significant benefits over existing options. Roche invests heavily in biotechnology and is the world¶s largest biotechnology company. quality and length of patients¶ lives. Focusing on Innovation By innovation we mean the creation and commercialization of medically differentiated products and services that lead to a tangible improvement to the health. Our aim is to develop new and improved drugs. At Roche we focus our resources on two research intensive businesses: pharmaceuticals and diagnostics. As a research-focused company we exploit the latest discoveries and technologies to develop our products. . This implies solving their problems and anticipating their future needs by maintaining close contact with them and listening to what they say. Serving Patients and Customers Roche¶s prime objective is to identify and meet the patient¶s and customers¶ needs. This is why Roche invested over 9 billion Swiss francs in 2010 on research and development. Roche continues its longstanding tradition of working in alliances with some of the most forward-looking and technologically advanced companies in the world.Where we are today Today Roche ranks among the world¶s leading healthcare companies and has two strong core businesses: diagnostics and pharmaceuticals. Within these businesses we priorities those areas of significant unmet need where we have the expertise to make a difference.
safer and more cost-effective. but the market is clearly shifting away from one size fits all products. Some of this variability is due to genetic and other biological differences between patients. One patient may be helped by treatment.Where we re going Personalized Healthcare Two patients can have the same diagnosis yet respond in different ways to the same medicine. Roche is a driving force behind this trend and already has several personalized healthcare products on the market. . This has enormous potential to make healthcare better. It will be a while before this potential is fully realized. One important aspect of personalizing medicine is the close interaction between pharmaceuticals and diagnostics. The fact that we are leaders in both these areas is a source of competitive advantage when it comes to meeting the healthcare challenges of the future. while the other experiences unwanted side effects without the desired clinical benefit. The idea of personalized healthcare is to use insights into these differences at the molecular level to develop treatments and tests tailored to the needs of specific patient populations.
as well as their families and communities Putting the health of patients first by providing educational programs.As a company. resources. and tools designed to help empower and inform Creating a challenging and rewarding work environment that inspires our employees . and delivering innovative. meaningful medicines and other healthcare solutions that help enrich the lives of patients. The people of AstraZeneca are dedicated to: Discovering. developing. AstraZeneca US is committed to a mission of improving human health.
Seven major therapy areas Sanofi-aventis focuses its activities on: Cardiovascular medicine Thrombosis Oncology internal medicine metabolic disorders diseases of the central nervous system vaccines .
cardiovascular disease. sanofi-aventis contributes directly to the development and implementation of the government's National Service Frameworks. . oncology. scientific societies and other healthcare organizations. Upheld daily by each of us through our actions and initiatives. As well as playing an active role in a wide range of healthcare charities. patient associations. internal medicine and vaccines . thrombosis.We share a strong set of values on which our individual and Group performance are founded. we work for what really matters: health. central nervous system disorders.are among those prioritized by government in its Health of the Nation objectives. Our dedicated Healthcare Development Managers work closely with NHS Trusts and leading medical experts all over the UK to optimize access to our products for those who stand to benefit the most and to help patients and clinicians gain greater understanding of the medical conditions concerned. metabolic disorders. Audacity-Creativity-Respect-Courage-Solidarity-Performance The seven therapy areas in which we specialize .
Thank You .